Real-world evidence reported for clinical efficacy evaluation in European Public Assessment Reports of authorised targeted therapies for solid malignancies: a comprehensive review (2018-2022)

Real-world evidence reported for clinical efficacy evaluation in European Public Assessment Reports of authorised targeted therapies for solid malignancies: a comprehensive review (2018-2022)

Background: The role of real-world evidence (RWE) for clinical efficacy regulatory evaluation remains unclear. We aimed to assess and describe the reported use of RWE for clinical efficacy evaluation of authorised targeted therapies for treatment of solid malignancies in Europe. Design: We studied a...

Full description

Saved in:
Bibliographic Details
Main Authors: J.W.G. Derksen, D. Martins-Branco, A. Valachis, A. Pellat, S.C.M.W. van Nassau, A. Aggarwal, G. Pentheroudakis, M. Koopman, L. Castelo-Branco, S. Delaloge
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:ESMO Real World Data and Digital Oncology
Subjects:
real-world evidence
targeted therapy
oncology
cancer
European medicines agency
marketing authorisation
Online Access:http://www.sciencedirect.com/science/article/pii/S2949820124000171
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2949820124000171

Similar Items